|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.310 USD | -36.89% |
|
-51.06% | -88.30% |
| 07-30 | Curis, Inc. Doses First Five Patients in TakeAim CLL Study | CI |
| 07-22 | Curis, Inc. - Special Call |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 5.15 | 8.56 | 9.804 |
| Spread/Res. | -55.15% | -73.01% | -76.44% |
| Spread/Supp. | +11.70% | +11.70% | +13.85% |
| Support | 2.068 | 2.068 | 2.029 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CRIS Stock
- Charts Curis, Inc.
Select your edition
All financial news and data tailored to specific country editions
